Solid Biosciences (SLDB) Cash from Investing Activities (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.80% |
| Dec 31, 2025 | 203.85% |
| Sep 30, 2025 | -38.31% |
| Jun 30, 2025 | -19.19% |
| Mar 31, 2025 | -171.21% |
| Dec 31, 2024 | 451.02% |
| Sep 30, 2024 | -112.27% |
| Jun 30, 2024 | 86.55% |
| Mar 31, 2024 | -184.97% |
| Dec 31, 2023 | 283.87% |
| Sep 30, 2023 | 48.92% |
| Jun 30, 2023 | -229.45% |
| Mar 31, 2023 | -43.63% |
| Dec 31, 2022 | 343.36% |
| Sep 30, 2022 | 125.02% |
| Jun 30, 2022 | -257.90% |
| Mar 31, 2022 | 25.08% |
| Dec 31, 2021 | 141.62% |
| Sep 30, 2021 | -48.84% |
| Jun 30, 2021 | -139,091.43% |
| Mar 31, 2021 | 41.67% |
| Dec 31, 2020 | 25.00% |
| Sep 30, 2020 | -124.84% |
| Jun 30, 2020 | -94.98% |
| Mar 31, 2020 | 124.80% |
| Dec 31, 2019 | -27.96% |
| Sep 30, 2019 | -83.59% |
| Jun 30, 2019 | 474.60% |
| Mar 31, 2019 | 69.69% |
| Dec 31, 2018 | -1,422.12% |
| Sep 30, 2018 | 43.90% |
| Jun 30, 2018 | -54.56% |
| Mar 31, 2018 | 42.65% |
| Dec 31, 2017 | 61.60% |
| Sep 30, 2017 | -153.75% |
| Jun 30, 2017 | 95.50% |